FDA Tries to Keep Up: FDA Publishes Two New Items Related to Artificial Intelligence | Arnall Golden Gregory LLP

FDA has recently published two much-anticipated items related to artificial intelligence (“AI”), one pertaining to medical devices and the other to drug manufacturing. FDA has cleared...

Related Keywords

,Device Software Functions ,European Union ,Submission Recommendations ,Predetermined Change Control Plan ,Machine Learning ,Enabled Device Software Functions ,Drug Manufacturing ,Impact Assessment ,Modification Protocol ,Modification Protocol Section ,Drug Manufacturers ,Artificial Intelligence Act ,